152 related articles for article (PubMed ID: 3158061)
1. Idiotypic-antiidiotypic interactions in man.
Geha RS
Ric Clin Lab; 1985; 15(1):1-8. PubMed ID: 3158061
[TBL] [Abstract][Full Text] [Related]
2. Idiotypic--anti-idiotypic interactions in man.
Geha RS
Am J Dis Child; 1985 Apr; 139(4):417-20. PubMed ID: 2579545
[No Abstract] [Full Text] [Related]
3. Idiotypic-antiidiotypic interactions in humans.
Geha RS
J Biol Response Mod; 1984 Dec; 3(6):573-9. PubMed ID: 6210347
[No Abstract] [Full Text] [Related]
4. Idiotypic control of the immune response.
Valderrama R; Eggers AE; Revan S; Moomjy M; Frost M; Pipia P; Di Paola M
J Neuroimmunol; 1988 Dec; 20(2-3):269-76. PubMed ID: 2461958
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic antibodies as vaccine candidates. The immune network.
Rico MJ; Hall RP
Arch Dermatol; 1989 Feb; 125(2):271-5. PubMed ID: 2643931
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of anti-idiotypic antibody].
Yachi A; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2313-20. PubMed ID: 2665652
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
8. Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies.
Geha RS; Comunale M
J Clin Invest; 1983 Jan; 71(1):46-54. PubMed ID: 6600236
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypes and immunity.
Kennedy RC; Melnick JL; Dreesman GR
Sci Am; 1986 Jul; 255(1):48-56. PubMed ID: 3487828
[No Abstract] [Full Text] [Related]
10. Anti-idiotypic antibodies and autoantibodies.
Zanetti M
Ann N Y Acad Sci; 1983; 418():363-78. PubMed ID: 6608905
[TBL] [Abstract][Full Text] [Related]
11. Evidence for idiotypic- and antiidiotypic B-B cellular interaction with the use of cloned antiidiotypic B cell line.
Bitoh S; Fujimoto S; Yamamoto H
J Immunol; 1990 Mar; 144(6):2046-52. PubMed ID: 2313088
[TBL] [Abstract][Full Text] [Related]
12. Participation of auto-anti-idiotypes in immune complex glomerulonephritis in rabbits.
Zanetti M; Wilson CB
J Immunol; 1983 Dec; 131(6):2781-3. PubMed ID: 6227667
[TBL] [Abstract][Full Text] [Related]
13. Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptor.
Amit T; Barkey RJ; Gavish M; Youdim MB
Endocrinology; 1986 Feb; 118(2):835-43. PubMed ID: 3002768
[TBL] [Abstract][Full Text] [Related]
14. [Idiotypes and the idiotypic network].
Youinou P
Presse Med; 1989 Dec 16-23; 18(42):2059-64. PubMed ID: 2481306
[TBL] [Abstract][Full Text] [Related]
15. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.
Forconi F; King CA; Sahota SS; Kennaway CK; Russell NH; Stevenson FK
Immunology; 2002 Sep; 107(1):39-45. PubMed ID: 12225361
[TBL] [Abstract][Full Text] [Related]
16. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application.
Tzioufas AG; Routsias JG
Autoimmun Rev; 2010 Jul; 9(9):631-3. PubMed ID: 20478412
[TBL] [Abstract][Full Text] [Related]
17. Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins.
Fine RM
Int J Dermatol; 1985 Nov; 24(9):560-1. PubMed ID: 2999010
[No Abstract] [Full Text] [Related]
18. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
19. Prediction of humoral immune responses to HLA through antiidiotypic antibody studies.
Reed E; McManus P; Ho E; Benvenisty A; Hardy M; McCabe R; Brensilver J; King DW; Suciu-Foca N
Transplant Proc; 1989 Feb; 21(1 Pt 1):708-10. PubMed ID: 2650235
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
